Bachra Choufi

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Catherine Thiéblemont, Hervé Tilly, María Gomes da Silva et al. · Journal of Clinical Oncology · 2017 · 189 citations

Elderly Patients, Immunology, Pathology +16

Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin–based reduced-intensity preparative regimen

Mohamad Mohty, Jacques‐Olivier Bay, Catherine Faucher et al. · Blood · 2003 · 185 citations · Full text

High total metabolic tumor volume at baseline predicts survival independent of response to therapy

Laëtitia Vercellino, Anne‐Ségolène Cottereau, Olivier Casasnovas et al. · Blood · 2020 · 176 citations · Full text

Results From a Prospective, Open-Label, Phase II Trial of Bendamustine in Refractory or Relapsed T-Cell Lymphomas: The BENTLY Trial

Gandhi Damaj, Rémy Gressin, Krimo Bouabdallah et al. · Journal of Clinical Oncology · 2012 · 160 citations · Full text

Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group

Frédéric Peyrade, Serge Bologna, Vincent Delwail et al. · The Lancet Haematology · 2016 · 113 citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +5